Morgan Stanley Grows More Bullish on JNJ Wednesday, October 20, 11:41 AM ET, by Market News Video Staff This morning, Morgan Stanley raised its EPS estimates on shares of Johnson & Johnson (JNJ) ...
JNJ Ordered to Pay $130M to Swiss Basilea Monday, November 29, 12:44 PM ET, by Market News Video Staff Johnson & Johnson (JNJ) shares are falling today after it was ordered to pay $130 ...
ENDP Price Target Increased to $48 Thursday, April 14, 3:24 PM ET, by Market News Video Staff Today, Citigroup (C) raised its price target on shares of Endo Pharmaceuticals Inc. (ENDP) from ...
Bullish Two Hundred Day Moving Average Cross - AZN Friday, April 15, 11:01 AM ET, by Market News Video Staff In trading on Friday, shares of AstraZeneca Plc (AZN) crossed above their 200 day moving ...
On 5/18/11, Allergan, Inc (NYSE:AGN) will trade ex-dividend, for its quarterly dividend of $0.05, payable on 6/10/11. As a percentage of AGN's recent stock price of $81.34, this dividend works out to approximately 0.06%.
Below is a dividend history chart for AGN, showing historical dividends prior to the most recent $0.05 declared by Allergan, Inc:
AGN Dividend History
Date
Div*
02/16/11
0.050
11/08/10
0.050
08/13/10
0.050
05/14/10
0.050
02/17/10
0.050
11/05/09
0.050
08/13/09
0.050
05/14/09
0.050
02/18/09
0.050
08/13/08
0.050
05/21/08
0.050
02/13/08
0.050
11/07/07
0.050
08/15/07
0.050
05/16/07
0.050
02/14/07
0.050
11/08/06
0.050
08/16/06
0.050
05/17/06
0.050
02/15/06
0.050
11/14/05
0.050
08/10/05
0.050
05/11/05
0.050
02/10/05
0.050
11/08/04
0.045
08/16/04
0.045
05/10/04
0.045
02/13/04
0.045
11/05/03
0.045
08/08/03
0.045
05/13/03
0.045
02/14/03
0.045
11/12/02
0.045
08/20/02
0.045
07/01/02
1.222
05/15/02
0.040
02/13/02
0.045
11/14/01
0.045
05/16/01
0.045
02/14/01
0.045
11/15/00
0.040
08/23/00
0.040
05/24/00
0.040
02/16/00
0.040
11/16/99
0.035
08/25/99
0.035
05/26/99
0.035
02/11/99
0.035
11/04/98
0.033
08/19/98
0.033
05/20/98
0.033
03/11/98
0.113
02/12/98
0.033
11/13/97
0.033
08/20/97
0.033
05/21/97
0.033
02/13/97
0.033
11/14/96
0.033
08/22/96
0.030
05/22/96
0.030
02/14/96
0.030
11/15/95
0.030
08/23/95
0.030
* Data may be adjusted for splits; we are not responsible for data errors; always verify data with the company.
In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from AGN is likely to continue, and whether the current estimated yield of 0.25% on annualized basis is a reasonable expectation of annual yield going forward.
According to the ETF Finder at ETF Channel, AGN makes up 4.45% of the SPDR S&P Pharmaceuticals ETF (AMEX:XPH) which is trading lower by about 0.5% on the day Monday.
AGN operates in the Drugs & Pharmaceuticals sector, among companies like Abbott Laboratories (NYSE:ABT) which is up about 0.5% today, and AstraZeneca Plc (NYSE:AZN) trading lower by about 0.3%. Below is a three month price history chart comparing the stock performance of AGN, versus ABT and AZN.
In Monday trading, Allergan, Inc shares are currently up about 0.8% on the day.
The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors —
anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset
allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors,
commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow
the performance trail wherever it leads us.
This Article's Word Cloud:AllerganBelowChannelDDDDDDDividendFFFFFFInvestmentMondayNYSEPharmaceuticalsaboutallowsalwaysassetbkgImagechartcompletelycurrentlydatadesigneddividenddividendsescapefillColorgridColorgrowthheighthistoryleftLabelsEverylikelylowermostotherperformanceportfoliopricerecentresponsibleshortshowVolumeTableshowingstockstocksthistradingverifywhatwhetherwhichyield
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.